Insulin-sensitizing agents in women with polycystic ovary syndrome.
Improvement of insulin resistance and, consequently, hyperinsulinemia is one of the main procedures for treating the polycystic ovary syndrome. The improvement of insulin resistance and the decrease in insulin concentration can be achieved in different ways: (1) by lifestyle modifications; (2) by using insulin sensitizing agents; and (3) by using antiandrogens.